[Toxoplasmosis].
D000328:Adult; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000962:Antimalarials / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007158:Immunologic Techniques; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000175:diagnosis / Q000188:drug therapy; D014124:Toxoplasmosis, Animal; D014125:Toxoplasmosis, Congenital
D000906:Antibodies; D000962:Antimalarials; D013449:Sulfonamides; D013411:Sulfadiazine; D011739:Pyrimethamine
La toxoplasmosi.